Ocugen IncEquity-NMS: OCGN
Equity-NMS: OCGN
$0.9
+0.11
(26 Feb)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$0.90
Open
$0.90
Today’s high
$0.99
Today’s low
$0.84
52W low
$0.34
52W high
$1.28
1Y
-7.79%
5Y
-34.77%
Shares O/S
256.50M
Market cap
230.85M
Insights
OCGN price is below its 200 day moving average
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Ocugen Inc

Ocugen, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing gene and cell therapies, biologics, and vaccines that improve health for patients across the globe. The Company's technology pipeline includes modifier gene therapy platform, regenerative medicine cell therapy platform, and biologic therapies for retinal diseases.

It is developing COVAXIN, which is a whole-virion inactivated intramuscular COVID-19 vaccine candidate for the North American market. It is also developing a inhaled mucosal vaccine platform, which includes OCU500, a bivalent COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and bivalent COVID-19 vaccine. Its modifier gene therapy platform is focused on addressing various retinal diseases, including retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), and Stargardt disease, with a single mutation-agnostic therapy. .


FAQs

Can I buy Ocugen Inc shares in India?
How to buy Ocugen Inc shares in India?
What is the share price of Ocugen Inc?
What is the Market Capitalization of Ocugen Inc?
What is the PE ratio of Ocugen Inc?
Is Ocugen Inc a good stock to buy?
In which sector / industry does Ocugen Inc operate?